News

Bank of America Securities Reiterated a Sell rating on Regeneron Pharmaceuticals (REGN), Lowered the PT
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is one of the Best Extremely Profitable Stocks to Buy Right Now . On July 22, ...
Investing Snacks6h
Unlock Regeneron’s Hidden Growth: A Value Investor’s Play
Regeneron presents an interesting investment case. Its valuation doesn't fully capture Dupixent's strength or its pipeline potential. Bears worry about Eylea's patent cliff, but this seems priced in.
Barchart on MSN8h
Regeneron Pharmaceuticals Earnings Preview: What to Expect
Tarrytown, New York-based Regeneron Pharmaceuticals, Inc. (REGN) discovers, invents, develops, manufactures, and ...
JPMorgan Initiates Coverage on Argan (AGX) with Neutral Rating Amid Energy Expansion
Argan, Inc. (NYSE:AGX) is one of the growth stocks that could double by 2027. On July 21, JPMorgan initiated coverage on AGX ...